Featured Research

from universities, journals, and other organizations

New Signaling Step For Key Player In Crohn's Disease

Date:
January 18, 2005
Source:
Cell Press
Summary:
This week, researchers report new findings that elucidate the role of NOD2, a key molecular player in Crohn's Disease, in the cellular signaling pathways that control inflammatory responses. NOD2's clinical relevance is clear from the fact that it is encoded by a Crohn's Disease susceptibility gene.

December 28, 2004 -- This week, researchers report new findings that elucidate the role of NOD2, a key molecular player in Crohn's Disease, in the cellular signaling pathways that control inflammatory responses. NOD2's clinical relevance is clear from the fact that it is encoded by a Crohn's Disease susceptibility gene. Understanding NOD2 has posed a particularly intriguing challenge for researchers because it appears able to somehow both activate and inhibit inflammatory cytokine responses in the cell. The work is reported by Lewis Cantley and colleagues at Harvard Medical School.

Related Articles


Crohn's Disease is an autoimmune inflammatory disorder of the gastrointestinal tract and is histologically characterized by inflammation, epithelial ulceration, fissure formation, and stenosis of segments of the entire gastrointestinal tract. The disease leads to significant morbidity and is thought to result from an inappropriate immune response to bacteria that normally inhabit the gastrointestinal tract. Because Crohn's Disease is characterized by too much initial acute inflammation, and, subsequently, too little subsequent negative regulation of that inflammatory response, pro-inflammatory and anti-inflammatory pathways appear to be faulty.

Previous work has shown that NOD2 acts as an intracellular receptor for bacteria and bacterial breakdown products, and because it appears capable of both activating and inhibiting inflammatory responses, NOD2 serves as a key integration point for the gastrointestinal tract's response to infectious organisms. The biochemical nature of NOD2's dichotomous role is unknown. In the new work, the researchers shed light on this problem by showing that NOD2 activation leads to the modification of NEMO, a central component of the NF-kB signaling pathway controlling inflammatory responses. NOD2 mutations responsible for Crohn's Disease cause polymorphisms that prevent the NOD2 protein from properly modifying NEMO. These results suggest that this previously unrecognized modification on a component of the major inflammatory signaling pathway in the body helps to integrate inflammatory signals. These results also suggest that this signaling mechanism may ultimately represent a pharmacological target for the amelioration of Crohn's Disease.

Derek W. Abbott, Andrew Wilkins, John M. Asara, and Lewis C. Cantley: "The Crohn's Disease Gene, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMO"

###

The other members of the research team include Derek W. Abbott of Brigham and Women's Hospital, Beth Israel Deaconess Hospital, and Harvard Medical School; Andrew Wilkins and John M. Asara of Beth Israel Deaconess Hospital. This work was supported by grant 1K08 AI53819-01A1 (D.W.A.), The Center for the Study of Inflammatory Bowel Disease, and Massachusetts General Hospital Pilot project grants DK43351 (L.C.C. and D.W.A.) and GM56203 (L.C.C.).

Publishing in Current Biology, Volume 14, Number 24, December 29, 2004, pages 2217–2227. http://www.current-biology.com


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Cite This Page:

Cell Press. "New Signaling Step For Key Player In Crohn's Disease." ScienceDaily. ScienceDaily, 18 January 2005. <www.sciencedaily.com/releases/2005/01/050111165947.htm>.
Cell Press. (2005, January 18). New Signaling Step For Key Player In Crohn's Disease. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2005/01/050111165947.htm
Cell Press. "New Signaling Step For Key Player In Crohn's Disease." ScienceDaily. www.sciencedaily.com/releases/2005/01/050111165947.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins